TRK fusions

From Libre Pathology
Revision as of 01:41, 11 September 2018 by Michael (talk | contribs) (→‎Association: ref)
Jump to navigation Jump to search

TRK fusions are seen in many solid tumours and have targeted drugs.


  • TRK1
  • TRK2
  • TRK3

The TRK genes are tyrosine kinase receptors.

Multiple fusion partners for each gene.


  • MASC.
  • Secretory breast carcinoma - ETV6-NTRK3.[1]


  • Merestinib.
  • Larotrectinib.
  • Others.

See also


  1. Vasudev, P.; Onuma, K. (Dec 2011). "Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression.". Arch Pathol Lab Med 135 (12): 1606-10. doi:10.5858/arpa.2010-0351-RS. PMID 22129193.